Development of recombinant cells encoding surface proteins of Corynebacterium pseudotuberculosis against caseous lymphadenitis in goats

Paper Details

Research Paper 01/08/2016
Views (164) Download (5)
current_issue_feature_image
publication_file

Development of recombinant cells encoding surface proteins of Corynebacterium pseudotuberculosis against caseous lymphadenitis in goats

Syafiqah Adilah Shahridon, M. Zamri-Saad M, Z. Zunita, M. Rozaihan
Int. J. Biosci.9( 2), 16-26, August 2016.
Certificate: IJB 2016 [Generate Certificate]

Abstract

Caseous lymhadenitis is an infectious disease caused by an intracellular bacterium, Corynebacterium pseudotuberculosis. Control is via vaccination. This report describes construction of two recombinant cells; one that carried the putative surface-anchored protein, the SpaA (pET32/LIC-SP31) and the other the glyceraldehyde-3-phosphate dehydrogenase protein, the GAPDH (pET32/LIC-SP40). The recombinant cells were introduced into goats before aAntibody response by the goats and protective capacities of the recombinant cells were measured. Fifteen goats were divided into3 groups. Group 1 was injected intramuscularly with PBS, Groups 2 and 3 were injected on days 0 and 14 with 106 CFU/ml of recombinant pET32/LIC-SP31 and pET32/LIC-SP40 cells, respectively. Serum samples were collected weekly to determine the antibody levels using ELISA. Two weeks after the last vaccination, all goats were challenged subcutaneously with 109 CFU/ml of live C. pseudotuberculosis. The results revealed that goats exposed to the recombinant cells showed significantly (p<0.05) higher IgG level compared to the control that lasted for 11 weeks. Generally, the exposed groups showed similar antibody pattern although those exposed to pET32/LIC-SP40 showed insignificantly (p>0.05) higher level in the first 7 weeks than the recombinant pET32/LIC-SP31. Following challenge at week 6, abscesses were observed in the lymph nodes of all groups while C. pseudotuberculosis was successfully isolated. The recombinant cells were able to induce humoral response but failed to protect the goats against challenge by live C. pseudotuberculosis.

VIEWS 2

Braga WU. 2007. Protection in alpacas against Corynebacterium pseudotuberculosis using different bacterial components. Veterinary Microbiology 119, 297-303.

Cameron CM, Maria M. 1971. Mechanism of immunity to Corynebacterium pseudotuberculosis (Buchanan, 1911) in mice using inactivated vaccine. Journal of Veterinary Research 38(2), 73-82.

Centikaya B, Karahan M, Atil E, Kalin R, De Baere T, Vaneechoutte M. 2002. Identification of Corynebacterium pseudotuberculosis isolates from sheep and goats by PCR. Veterinary Microbiology 88, 75-83.

Desvaux M, Dumas E, Chafsey I, Hebraud M. 2006. Protein cell surface display in Gram-positive bacteria: from single protein to macromolecular protein structure. Federation of European Microbiology Society 256, 1-15.

Dorella FA, Pacheco LGC, Oliviera SC, Miyoshi A, Azevedo V. 2006. Corynebacterium pseudotuberculosis: Microbiology, biochemical properties, pathogenesis and molecular studies of virulence. Veterinary Research 37, 201-218.

Fontaine MC, Baird GC. 2008. Caseous lymphadenitis. Small Ruminant Research 76, 42-48.

Guimarães AS, Carmo FB, Pauletti RB, Seyffert N, RibeiroD, Lage AP, Heinemann MB, Miyoshi A, Azevedo V, Gouveia AMG. 2011. Caseous lymphadenitis: Epidemiology, diagnosis and control. Institute of Integrative Omics and Applied Biotechnology Journal 2, 33-43.

Hoelzle LE, Scherrer T, Muntwyler J, Wittenbrink MM, Philipp W, Hoelzle K. 2013. Differences in the antigen structures of Corynebacterium pseudotuberculosis and the induced humoral immune response in sheep and goats. Veterinary Microbiology 164, 359-365.

Izgur M, Akan M, Ilhan Z, Yazicioglu N. 2010. Studies on vaccine development for ovine caseous lymphadenitis. Ankara Universiti Veteriner Fakultesi Dergisi 57, 161-165.

Literak I, Horvathova A, Jahnova M, Rychlik I, Skalka B. 1999. Phenotype and genotype characteristics of the Slovak and Czech Corynebacterium pseudotuberculosis strains isolated from sheep and goats. Small Ruminant Research 32, 107-111.

Nascimento IP, Leite LCC. 2012. Recombinant vaccines and development of new vaccine strategies. Brazillian Journal of Medicine and Biological Research 45, 1102-1111.

Nur-Nazifah M, Sabri MY, Siti-Zahrah A. 2014. Development and efficacy of feed-based recombinant vaccine encoding the cell wall surface anchor family protein of Streptococcus agalactiae against streptococcosis in Oreochromis sp. Fish and Shellfish Immunology 37, 193-200.

Oliveira L, Madureira P, Andrade EB, Bouaboud A, Morello E, Ferreira P, Poyart C, Trieu-Cuot P, Dramsi S. 2012. Group B Streptococcus GAPDH is released upon cell lysis, associate with bacterial surface, and induces apoptosis in murine macrophages. Plos –one 7(1), e29963.

Pacheco LGC, Slade SE, Seyffert N, Santos A R, Castro TLP, Silva WM, Santos AV, Santos SG, Farias LM, Carvalho MAR, Pimenta AMC, Meyer R, Silva A, Scrivens JH, Oliveira SC, Miyoshi A, Dowson CG, Azevedo V. 2011. A combined approach for comparative exoproteome analysis of Corynebacterium pseudotuberculosis. BMC Microbiology 11, 12-25.

Paule BJA, Azevedo V, Regis LF, Carminati R, Bahia CR, Vale VLC, Moura-Costa LF, Freire SM, Nascimento I, Schaer R, Goes AM, Meyer R. 2003. Experimental Corynebacterium pseudotuberculosis primary infection in goats: Kinetics of IgG and interferon-g production, IgG avidity and antigen recognition by western blotting. Veterinary Immunology and Immunopathology 96, 129-139.

Paule BJA, Meyer R, Moura-Costa LF, Bahia RC, Carminati R, Regis LF, Vale VLC, Freire SM, Nascimento I, Schaer R, Azevedo V. 2004. Three-phase partitioning as an efficient method for extraction/concentration of immunoreactive excreted–secreted proteins of Corynebacterium pseudotuberculosis. Protein Extraction and Purification 34, 311-316.

Ribeiro D, Rocha FS, Leite KMC, Soares SC, Silva A, Portela RWD, Meyer R, Miyoshi A, Oliveira SC, Azevedo V, Dorella FA. 2014. An iron-acquisition-deficient mutant of Corynebacterium pseudotuberculosis efficiently protects mice against challenge. Veterinary Research 45, 28-33.

Rogers EA, Das A, Ton-That H. 2011. Adhesion by pathogenic Corynebacteria. Advances in Experimental Medicine and Biology 715, 91-103.

Sabri MY, Zamri-Saad M, Mutalib AR, Israf DA, Muniandy N. 2000. Efficacy of an outer membrane protein of Pasteurella haemolytica A2, A7 or A9-enriched vaccine against intratracheal challenge exposure in sheep. Veterinary Microbiology 73, 13-23.

Schneewind O, Missiakas D. 2014. Sec-secretion and sortase-mediated anchoring of proteins in Gram-positive bacteria. Biochimica et Biophysica Acta 1843, 1687-1697.

Silva WM, Seyffert N, Santos AV, Castro TLP, Pacheco LGC, Santos AR, Ciprandi A, Dorella FA, Andrade HM, Barh D, Pimenta AMC, Silva A, Miyoshi A, Azevedo V. 2013. Identification of 11 new exoproteins in Corynebacterium pseudotuberculosis by comparative analysis of exoproteome. Microbial Pathogenesis 61-62, 37-42.

Simmons CP, Dunstan SJ, Tachedjian M, Krywult J, Hodgson ALM, Strugnell RA. 1998. Vaccine potential of attenuated mutants of Corynebacterium pseudotuberculosis in sheep. Infection and Immunity 66, 474-479.

Trost E, Ott L, Schneider J, Schroder J, Sebastian J, Goesmann A, Husemann P, Stoyes J, Dorella FA, Rochas FS, Soares SC, D’Afonseca V, Miyoshi A, Ruiz J, Silvas A, Azevedo V, Burkovski A, Guiso N, Join-Lambert OF, Kayal S, Tauch A.  2010. The complete genome sequence of Corynebacterium pseudotuberculosis FRC41 isolated from a 12-year-old girl with necrotizing lymphadenitis reveals insights into gene regulatory networks contributing to virulence. BMC Genomics 11, 728-748.